Editorial Policies

Focus and Scope

J.Pharm.Sci.Community publishes original, previously unpublished research articles, review articles, as well as short communication in various pharmaceutical fields. Paper topics include the following:

Pharmaceutical Technology and Pharmaceutics
Pharmaceutical Analysis
Medicinal Chemistry
Pharmacology and Toxicology
Pharmaceutical Biology and Biotechnology
Pharmacognosy and Phytochemistry
Social Behavior and Administrative Pharmacy
Pharmacoeconomics
Clinical Pharmacy

Section Policies

Articles

Open Submissions

Indexed

Peer Reviewed

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

Publication Ethics and Malpractice Statement

Journal of Pharmaceutical Sciences and Community is a peer-reviewed journal. It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer and the publisher. This statement is based on Practice Guidelines for publication as in Committee on Publication Ethics (COPE’s Best).

In addition, every full paper submitted to J. Pharm. Sci. Community will be screened using Turnitin (an Internet-based plagiarism-prevention service) to detect the possibilities of plagiarism.

AUTHORS

Reporting Standard

Authors are expected to have made reasonable attempts to check and validate results submitted to the journal for publication.
Authors should provide real and authentic research data.
Authors should confirm that the journal is not published in another journal.
Authors are required to cite the sources correctly by considering the content of the manuscript either in the form of written publications and personal interviews.

Originality and plagiarism

The authors should confirm that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant, or Concurrent Publication

Authors should not submit or publish the same manuscript to more than one journal or primary publication.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported research.
All those who have made significant contributions should be listed as co-authors.
Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should in any event be prepared to keep such data for a reasonable time after publication.

Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript.
All sources of financial support for the project should be disclosed.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.
If the editor or the publisher learns from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

EDITORS

Fair Play

An editor assesses manuscripts based only on the originality and the quality of the paper and should not be affected by the religious, national, political or any other influences.

Confidentiality

The editors and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and Conflicts of Interest

Unpublished materials disclosed in a submitted manuscript must not be used in editors' own research without the express written consent of the author.

PEER REVIEWERS

Contribution to Editorial Decisions

Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author to give proper assessment and judgement of the submitted paper.
Reviewers should immediately inform the editor if any form of plagiarism is identified within submitted work.

Promptness

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editors and excuse himself from the review process.

Confidentiality

Any manuscripts received for review must be treated as confidential documents. They must not be shown to, or discussed with others except as authorized by the editor.

Standards of Objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. The reviewers should express their views clearly with supporting rationale arguments.

Acknowledgement of Sources

Reviewers should point out on relevant published work which is not cited in the article.
Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation.
A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships with any of the authors or institutions connected to the papers.

PUBLISHER

J. Pharm. Sci. Community is committed to ensuring that commercial interest has no impact or influence on editorial decisions.
J. Pharm. Sci. Community will assist in communications with other journals where this is useful to the authors.
J. Pharm. Sci. Community is working closely with all related divisions to set standards for best practices on ethical matters, errors and retractions--and are prepared to provide specialized legal review and counsel if necessary.

Publication Frequency

Journal of Pharmaceutical Sciences and Community is published by Faculty of Pharmacy, Universitas Sanata Dharma. J. Pharm. Sci. Community is published twice every year (May and November).

Peer Review Process

Peer review process in the J. Pharm. Sci. Community carried out through double-blind peer review by considering two main aspects, namely: relevance and contribution of articles on pharmaceutical sciences and/or community health theory and practical development. Editors and reviewers provide constructive feedback on the evaluation results to the author.

The duration of the review process in J. Pharm. Sci. Community is 4 to 12 weeks. This review period depends on the board of reviewers. The stages of the review process applied at J. Pharm. Sci. Community are as follows:

Submission of manuscripts is only processed via journal system of J. Pharm. Sci. Community, website: https://e-journal.usd.ac.id/index.php/JFSK/index.
The incoming manuscripts will be checked whether it matches the focus and scope of Journal of Pharmaceutical Sciences and Community. The manuscripts will be reviewed at the editorial level to find out whether it contributes sufficiently to the development of science and practice in the field of pharmaceutical sciences and/or community health. The editor will inform whether the manuscripts are in accordance with the journal's focus and scope. If appropriate, the next process will be carried out. If not, the manuscript will be returned to the Author(s) accordingly.
The manuscripts will be checked with Turnitin (similarity check). If more than 25% level of similarity, the manuscripts will be asked to be repaired or rejected by the journal's editor. This decision is entirely the prerogative right of the editor in chief and cannot be contested. Manuscripts that qualify at this stage will proceed to the review stage by peer reviewers.
For manuscript that is accepted with revisions (minor or major), it will contain comments from peer reviewers and be returned to the author to be revised. Referring to the policy in J. Pharm. Sci. Community, reviewers only give suggestions on whether the manuscript is accepted or rejected. Meanwhile, the final decision regarding the acceptance or rejection of the manuscript is in the hand of the editor.
The author is given the time to revise the manuscript no later than one month. Extra time to revise should be asked to editor via email (editorial.jpsc@usd.ac.id). Once the revision time is due without any revision submitted, the manuscript will be rejected or returned to the Author(s).
Accepted manuscript will be published in J. Pharm. Sci. Community in the edition managed by the editor.

If the author needs help with the submission process, guidance to use the Open Journal System, or does not get confirmation from J. Pharm. Sci. Community for long time, author can contact our journal manager by email at editorial.jpsc@usd.ac.id.

Plagiarism Screening

Every full paper submitted to J. Pharm. Sci. Community will be screened using Turnitin (an Internet-based plagiarism-prevention service) to detect the possibilities of plagiarism.

Article Submission Charge (ASC)

Article submission charge (ASC) in J. Pharm. Sci. Community is free of charge; there is no article submission charge (without any ASC).

Article Processing Charge (APC)

Article processing charge (APC) in J. Pharm. Sci. Community is 800,000.00 IDR (Rp. 800.000,00; delapan ratus ribu rupiah). The APC will be charge after the acceptance of manuscript.The APC will be applied for submissions after June 14th, 2022.

Order Journal

Subscription form for ordering the hardcopy of the journal can be download here . The filled and signed subscription form may be sent via email to editorial.jpsc@usd.ac.id with the subject Order Journal.

After receiving invoice details from the subscription managers, all payments should be made via transfer to CIMB Niaga (Account holder: Lembaga Penelitian Univ. Sanata Dharma, Account Nr. 800077540800).

The order will be executed when payment has been made and the proof of payment has been scanned and sent accordingly.

Indexing

J Pharm Sci Community is indexed by:

AI Tools Usage Policy

1. Introduction
The J. Pharm. Sci. Community acknowledges that AI (Artificial Intelligence) technology is now increasingly used in academic fields. AI offers features for improving language quality, organizing data, and supporting analytical work. However, at the same time, the use of AI requires ethical consideration to determine its boundaries. This policy is created to encourage the responsible use of AI in manuscript preparation and to ensure that the submitted manuscripts comply with COPE standards on publication integrity.

2. Appropriate Use of AI
AI may be used to support manuscript preparation as long as its role is an assisting tool and not the primary creator. Permitted examples include:

l Improving grammar, syntax, and sentence readability

l Assisting with reference formatting

l Conducting initial literature studies

l Supporting data visualization

l Translating text with accuracy verified by the user

Every output must be carefully reviewed, corrected, and validated by the authors before submission.

3. Unacceptable Use of AI
J. Pharm. Sci. Community strongly discourages the use of AI in contexts where AI replaces the academic role, originality, or analysis of the authors. AI tools must not be used to:

l Create the scientific content of a manuscript (such as background, methods, data interpretation, results and discussion, and conclusions)

l Manipulate data, analyses, images, or chemical/biological structures

l Create text that paraphrases published work

l Conduct statistical analysis, generate hypotheses, or make decisions in place of the authors

l Create or modify images (clinical data, laboratory results, micrographs, and others) unless openly documented and ethically justified

l Prevent plagiarism from being detected

Use of AI that compromises research validity and ethical publication practices will be considered as misconduct.

4. Responsibilities of Authors
Authors are responsible for the entirety of the submitted manuscript, whether with AI contributions or without AI contributions. Authors must:

l Independently ensure that every AI output is verified for accuracy, including citation correctness and conceptual validity

l Ensure that no AI-generated content contains errors, data manipulation, or unoriginal text

l Guarantee that the use of AI does not violate copyright, privacy, or data ownership

l Ensure that all intellectual contributions originate from human authors

Understand that AI cannot be listed as an author, collaborator, or contributor at any situation

5. Disclosure Requirements
The use of AI beyond basic proofreading must be transparently declared. The disclosure must include:

l The AI tool used, including its type and version

l A brief description of the role of AI in the manuscript

l A statement acknowledging that all authors reviewed and take full responsibility for all AI-generated content

The disclosure may be written in the Acknowledgments section or another appropriate section.

6. Editorial Handling and Peer Review
Manuscripts submitted to J. Pharm. Sci. Community, whether created with AI or not, will undergo the standard peer-review process. The editorial board may request clarification if the use of AI does not comply with this policy.
If there is suspicion of unacceptable AI use, the editorial board may:

l Request a detailed explanation from the authors

l Return the manuscript for revision

l Reject the manuscript

l Follow COPE procedures regarding research ethics violations

7. Ethical Considerations
The use of AI must respect basic research ethics principles, such as:

l Academic integrity

l Transparency and accountability

l Protection of confidential and sensitive data

l Avoidance of plagiarism and inappropriate text reuse

AI-generated content that violates this policy will result in actions in accordance with COPE guidelines.

8. Policy Continuity and Updates
AI technology evolves rapidly. As a result, J. Pharm. Sci. Community will periodically review and revise this policy so that it remains relevant, practical, and ethical. Authors are encouraged to consult the latest version of this policy before submitting.

9. Inquiries
Questions regarding this policy may be addressed to the editorial board of the Journal of Pharmaceutical Sciences and Community.